'Acquired resistance' presentation slideshows

Acquired resistance - PowerPoint PPT Presentation

YIR On Demand Lung

YIR On Demand Lung

★ ★ ★ ★ ★

858 views • 84 slides
Victor Cohen, MDCM, FRCPC Department of Oncology Segal Cancer Center

Victor Cohen, MDCM, FRCPC Department of Oncology Segal Cancer Center

★ ★ ★ ★ ★

910 views • 62 slides
DR-TB

DR-TB

DR-TB. Dr. Magdy Fawzy NTP, EGYPT PAL Coordinator. Causes of drug-resistant tuberculosis: From a microbiological perspective, resistance is caused by a genetic mutation.

★ ★ ★ ★ ★

637 views • 49 slides
Robert S. Kerbel, PhD Canada Research Chair in Tumor Biology,

Robert S. Kerbel, PhD Canada Research Chair in Tumor Biology,

★ ★ ★ ★ ★

492 views • 33 slides
Acquired Resistance Patient Forum

Acquired Resistance Patient Forum

Combinations for Treating EGFR Acquired Resistance. Melissa L. Johnson, MD. Acquired Resistance Patient Forum. In ALK, ROS1 & EGFR Lung Cancers. September 6, 2014 | Boston. Combination Treatments for EGFR Acquired Resistance. Dx : EGFR+ lung cancer. Acquired Resistance.

★ ★ ★ ★ ★

613 views • 27 slides
Acquired Resistance Patient Forum

Acquired Resistance Patient Forum

Life After Erlotinib : What Next?. Jared Weiss Vice President, Cancergrace Assistant Professor of Medicine, UNC Lineberger Comprehensive Cancer Center. Acquired Resistance Patient Forum. In ALK, ROS1 & EGFR Lung Cancers. September 6, 2014 | Boston.

★ ★ ★ ★ ★

838 views • 25 slides
What is Acquired Resistance? and How Does it Occur?

What is Acquired Resistance? and How Does it Occur?

What is Acquired Resistance? and How Does it Occur?. Gregory J. Riely @ RielyMD. Primary Resistance. Kwak EL, et al. NEJM 2010;363:1693-1703. Acquired Resistance. Acquired Resistance. Kwak EL, et al. NEJM 2010;363:1693-1703. Crizotinib improves PFS compared to chemo.

★ ★ ★ ★ ★

467 views • 25 slides
Control of Microbial Growth 2

Control of Microbial Growth 2

N.B. Due to a seminar, the Monday morning help session on December 5th will be changed to the following: Help Sessions in room M245: Monday, December 5th, 10-11 am & 2-3 pm. Tuesday, December 6th, 11 am-noon & 2-3 pm. 30 November 2005 M.S. Peppler Dept of MMI mark.peppler@ualberta.ca

★ ★ ★ ★ ★

376 views • 23 slides
Janjigian YY et al. Proc ASCO 2011;Abstract 7525.

Janjigian YY et al. Proc ASCO 2011;Abstract 7525.

Activity and Tolerability of Afatinib (BIBW 2992) and Cetuximab in NSCLC Patients with Acquired Resistance to Erlotinib or Gefitinib. Janjigian YY et al. Proc ASCO 2011;Abstract 7525. Introduction.

★ ★ ★ ★ ★

225 views • 8 slides

View Acquired resistance PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Acquired resistance PowerPoint presentations. You can view or download Acquired resistance presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.